biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Tailwinds Research and Screen Door Manufac

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on May 15, 2023 4:51pm

148 Views

Post# 35449051

RE:RE:RE:Tailwinds Research and Screen Door Manufac

Boomskid wrote: I talk about it all the time, TheTrooth. I'm not anonymous. I gave at the office.

I may Ferniesh you with more info soon.

jd

Yeah. Sure you will John.

Always little secrets and hints with you. That helps you believe that you are actually still relevant in this story.

News flash. You aren't.

Haven't been for years.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale